LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative Platform Providence Therapeutics has developed an integrated mRNA platform with capabilities in design, manufacturing, and targeted delivery, making it a valuable partner for organizations seeking advanced RNA-based therapeutics and vaccines.

Strategic Collaborations Recent partnerships with Southern RNA and University Health Network position Providence as a collaborative leader in personalized cancer vaccines and infectious disease therapeutics, opening opportunities for joint development and licensing deals.

Recent Focus Shift Originally founded for cancer vaccine development, Providence has expanded into COVID-19 vaccine development and broader infectious diseases, presenting potential avenues for companies interested in vaccine supply and contract manufacturing services.

Growth Potential With revenue estimated between $10 million and $25 million and ongoing funding, Providence is poised for growth, offering potential for strategic investments, licensing agreements, or technology partnerships to scale innovative RNA solutions.

Market Position Positioned as a competitive player in the mRNA space with a strong focus on platform scalability and organ targeting, Providence presents compelling opportunities for suppliers of raw materials, formulation components, and manufacturing equipment tailored to high-precision RNA therapeutics.

Providence Therapeutics Tech Stack

Providence Therapeutics uses 8 technology products and services including Amazon Web Services, Bunny, Open Graph, and more. Explore Providence Therapeutics's tech stack below.

  • Amazon Web Services
    Cloud Hosting
  • Bunny
    Content Delivery Network
  • Open Graph
    Content Management System
  • Cloudflare Bot Management
    Security
  • UIKit
    UI Frameworks
  • X-Content-Type-Options
    Web & Portal Technology
  • GoDaddy
    Web Hosting
  • Facebook
    Widgets

Media & News

Providence Therapeutics's Email Address Formats

Providence Therapeutics uses at least 1 format(s):
Providence Therapeutics Email FormatsExamplePercentage
First.Last@providencetherapeutics.comJohn.Doe@providencetherapeutics.com
88%
First@providencetherapeutics.comJohn@providencetherapeutics.com
8%
FMLast@providencetherapeutics.comJMDoe@providencetherapeutics.com
2%
First.Middle@providencetherapeutics.comJohn.Michael@providencetherapeutics.com
2%

Frequently Asked Questions

What is Providence Therapeutics's official website and social media links?

Minus sign iconPlus sign iconProvidence Therapeutics's official website is providencetherapeutics.com and has social profiles on LinkedInCrunchbase.

What is Providence Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign iconProvidence Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Providence Therapeutics have currently?

Minus sign iconPlus sign iconAs of December 2025, Providence Therapeutics has approximately 60 employees across 2 continents, including North AmericaAsia. Key team members include Chief Science Officer: N. M. O.Vice President Regulatory Affairs: M. G.President & Ceo: B. S.. Explore Providence Therapeutics's employee directory with LeadIQ.

What industry does Providence Therapeutics belong to?

Minus sign iconPlus sign iconProvidence Therapeutics operates in the Biotechnology Research industry.

What technology does Providence Therapeutics use?

Minus sign iconPlus sign iconProvidence Therapeutics's tech stack includes Amazon Web ServicesBunnyOpen GraphCloudflare Bot ManagementUIKitX-Content-Type-OptionsGoDaddyFacebook.

What is Providence Therapeutics's email format?

Minus sign iconPlus sign iconProvidence Therapeutics's email format typically follows the pattern of First.Last@providencetherapeutics.com. Find more Providence Therapeutics email formats with LeadIQ.

How much funding has Providence Therapeutics raised to date?

Minus sign iconPlus sign icon As of December 2025, Providence Therapeutics has raised $2.1M in funding. The last funding round occurred on Dec 07, 2021 for $2.1M.

When was Providence Therapeutics founded?

Minus sign iconPlus sign iconProvidence Therapeutics was founded in 2015.

Providence Therapeutics

Biotechnology ResearchAlberta, Canada51-200 Employees

Providence Therapeutics Holdings Inc is a clinical-stage biotechnology company focused on drug development and platform development. 
 
The Providence mRNA Medicines platform is comprised of three integrated platforms: 1) mRNA Medicines Platform, 2) INTENT™ Lipid Nanoparticle Platform (LNP), and 3) Manufacturing Platform. Providence’s mRNA and INTENT™ LNP platform offer an end-to-end solution for designing codon-optimized ultrapure mRNA that can be formulated in application optimized LNP. The Providence proprietary  INTENT™ LNP platform, consists of rationally designed lipids that have been tested for suitability for programs in oncology, infectious diseases and gene delivery. 
 
Our scalable, efficient platform demonstrates differentiated capabilities in mRNA design, manufacturing, and formulation processes, as well as specific organ and tissue targeting. For more information, please visit providencetherapeutics.com

Section iconCompany Overview

Website
providencetherapeutics.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $2.1M

    Providence Therapeutics has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Dec 07, 2021 in the amount of $2.1Mas a funding.

  • $10M$25M

    Providence Therapeutics's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $2.1M

    Providence Therapeutics has raised a total of $2.1M of funding over 1 rounds. Their latest funding round was raised on Dec 07, 2021 in the amount of $2.1Mas a funding.

  • $10M$25M

    Providence Therapeutics's revenue is estimated to be in the range of $10M$25M

Company Leadership

  • Stylized image of a person
    N. M. O.
    Chief Science Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Vice President Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. S.
    President & Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. R.
    Consultant Cmo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. S.
    Senior Vice President Shared Services
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    M. G.
    Vice President Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. S.
    Director - Analytical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. S.
    Director Of Partnerships And Innovation
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. S.
    Senior Director, People & Culture
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. O.
    Director
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.